<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2369-3-10.anc" start="2052" end="2056" sStart="2027" offset="25" sid="r7.1.use.v.0341" wn="1" wnkey="use%2:34:01::" text="SAF.TXUNOS was used as the primary dataset, and merged with variables from SAF.HOSP for hospitalization data, and SAF.PATIENTS for dates and causes of death as well as causes of renal disease, as previously reported [ 6 7 8 ] . Patient characteristics and treatment factors were those at the date of transplant." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2369-3-10.anc" start="9150" end="9155" sStart="null" offset="119" sid="r7.1.use.v.0152" wn="1" wnkey="use%2:34:01::" text="Because hospitalizations for poisonings were uncommon, Poisson Regression was used for validation, using the GENLOG approximation in SPSS." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2369-3-10.anc" start="17011" end="17018" sStart="null" offset="21" sid="r8.suggest.v.0632" wn="1" wnkey="suggest%2:32:00::" text="Until then, we would suggest that the possibility of other drug toxicities, including drug interactions, be thoroughly excluded before prescribing benzodiazepines in this population." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2369-3-10.anc" start="18842" end="18853" sStart="null" offset="61" sid="r11.recommend.v.0458" wn="2147483645" wnkey="null" text="However, in a small percentage of patients currently recommended doses may still result in toxicity." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2369-3-10.anc" start="6202" end="6206" sStart="null" offset="188" sid="r9.late.j.0207" wn="2" wnkey="late%5:00:00:unpunctual:00" text="Episodes of rejection were not restricted to those occurring in the first year, in contrast to studies of allograft function, since there is no evidence that late (vs." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2369-3-10.anc" start="17507" end="17511" sStart="null" offset="117" sid="r10.high.j.0321" wn="1" wnkey="high%3:00:02::" text="The high frequency of poisonings due to insulin/antidiabetic agents is also not surprising given the high frequency of diabetes among renal transplant recipients, although diabetes was not an independent risk factor for poisonings in the present analysis." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2369-3-10.anc" start="5426" end="5434" sStart="null" offset="575" sid="r11.function.n.0753" wn="2" wnkey="function%1:07:00::" text="The independent associations between patient factors and hospitalizations for poisonings were examined using multivariate analysis with stepwise Cox Regression (likelihood ratio method) including recipient and donor age, recipient race, gender, weight, pretransplant dialysis (yes/no), year of transplant, duration of dialysis prior to transplantation, total follow-up time, repeat transplant, donor cytomegalovirus serology, dialysis in the first week after transplant (delayed graft function, yes/no), rejection (diagnosis or treatment) occurring during the first six months after transplant, induction antibody therapy, maintenance immunosuppressive medications at time of discharge after transplant surgery, graft loss (analyzed as a time-dependent covariate as previously described), [ 9 ] and cause of ESRD (diabetes, systemic lupus erythematosus (because of the potential effect of corticosteroid therapy prior to renal transplantation), hypertension and glomerulonephritis)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2369-3-10.anc" start="16545" end="16551" sStart="null" offset="120" sid="r10.common.j.0283" wn="4" wnkey="common%5:00:00:familiar:02" text="It is noteworthy that calcineurin inhibitor toxicity may mimic anxiety or nervousness, [ 16 ] which are common indications for the use of benzodiazepines." />
  </sentences>
</list>